Jazz Pharmaceuticals PLC

Healthcare · Biotechnology

238.00$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Jazz Pharmaceuticals PLC (JAZZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 11,659 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JAZZ
Line item	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	–	165	215	208	117	107	136	254	1,966	2,238	3,339	3,360	4,800	5,124	5,203	5,539	6,536	12,299	10,835	11,393	12,012	11,659
Current Assets	–	31	92	116	44	37	74	199	552	865	1,016	1,258	748	968	1,234	1,630	2,840	2,611	2,606	3,435	4,629	4,166
Cash	–	21	79	103	25	16	45	82	387	637	684	989	366	386	310	637	1,058	591	881	1,506	2,413	1,392
Cash & Short-Term Investments	–	21	79	103	26	16	45	158	387	637	684	989	426	601	825	1,077	2,133	591	881	1,626	2,993	2,442
Receivables	–	3.6	5.4	5.4	6.6	12	22	34	75	125	186	210	234	224	264	356	396	563	651	706	717	831
Inventory	–	3.3	3.0	2.2	4.8	3.4	5.0	3.9	27	29	30	19	34	43	53	79	95	1,073	714	597	480	417
Property, Plant & Equipment	–	1.9	2.1	3.9	2.5	1.1	0.7	1.6	7.3	14	58	86	107	170	200	271	128	343	301	–	–	–
Goodwill	–	39	38	38	38	38	38	38	443	450	703	657	894	948	928	920	958	1,828	1,693	1,753	1,716	1,829
Intangible Assets	–	79	69	36	33	30	22	15	870	812	1,437	1,186	3,012	2,979	2,731	2,441	2,195	7,152	5,794	5,418	4,756	4,430
Total Liabilities	–	283	391	153	210	180	105	61	845	943	1,968	1,761	2,923	2,411	2,446	2,428	2,876	8,333	7,750	7,656	7,919	7,341
Current Liabilities	–	23	31	37	173	59	60	53	192	204	217	227	257	294	345	364	654	809	933	1,537	1,039	2,243
Short-Term Debt	–	–	2.2	3.5	122	33	23	39	30	5.6	9.4	38	36	41	33	46	261	47	47	624	46	1,045
Accounts Payable	–	4.8	5.4	2.9	5.7	2.2	3.0	5.1	16	21	25	22	22	24	41	48	27	100	91	103	78	122
Long-Term Debt	–	89	74	75	–	91	25	0.0	427	544	1,333	1,167	1,994	1,540	1,563	1,574	1,849	6,019	5,693	5,108	6,078	4,328
Shareholders' Equity	–	-118	-176	55	-93	-73	31	193	1,121	1,296	1,371	1,599	1,877	2,713	2,757	3,111	3,660	3,965	3,086	3,737	4,094	4,319
Retained Earnings	–	-118	-178	-316	-501	-508	-475	-350	-61	19	35	303	529	918	841	1,068	1,160	830	734	879	1,127	646
Shares Outstanding	13	13	13	14	26	30	39	47	60	62	63	63	62	61	61	58	57	60	63	72	66	61

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings